JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M205930200 on June 24, 2002

J. Biol. Chem., Vol. 277, Issue 38, 35616-35624, September 20, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/38/35616    most recent
M205930200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Persson, K. E. M.
Right arrow Articles by Stenflo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Persson, K. E. M.
Right arrow Articles by Stenflo, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The N-terminal Epidermal Growth Factor-like Domain of Coagulation Factor IX
PROBING ITS FUNCTIONS IN THE ACTIVATION OF FACTOR IX AND FACTOR X WITH A MONOCLONAL ANTIBODY*

Kristina E. M. PerssonDagger , Bruno O. Villoutreix§, Ann-Marie ThämlitzDagger , Karin E. Knobe||, and Johan StenfloDagger **

From the Departments of Dagger  Clinical Chemistry and || Pediatrics, Lund University, University Hospital, Malmö, S-205 02 Malmö, Sweden and the § Institut National de la Santé et de la Recherche Médicale, INSERM U428, Université Paris V, 4 Ave de L'Observatoire, Paris 75006, France

The absence or reduced activity of coagulation factor IX (FIX) causes the severe bleeding disorder hemophilia B. FIX contains an N-terminal Gla domain followed by two epidermal growth factor-like (EGF) domains and a serine protease domain. In this study, the epitope of monoclonal antibody AW, which is directed against the C-terminal part of the first EGF domain in human FIX, was defined, and the antibody was used to study interactions between the EGF domain of FIX and other coagulation proteins. Antibody AW completely blocks activation of FIX by activated factor XI, but activation by activated factor FVII-tissue factor is inhibited only slightly. The antibody also causes a marginal reduction in the apparent kcat for factor X both in the presence and absence of activated factor VIII. Based on these results, we produced a preliminary model of the structure of the activated factor IX-activated factor VIII-AW complex on the surface of phospholipid. The model suggests that in the Xase complex, EGF1 of activated factor IX is not involved in direct binding to activated factor VIII. Studies of the interaction of antibody AW with a mutated FIX molecule (R94D) also suggest that the Glu78-Arg94 salt bridge is not important for maintaining the structure of FIX.


* This work was supported by Malmö University Hospital, the Swedish Research Council (Medicine), and the Swedish Governmental Funding for Clinical Research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by the Avenir Program (INSERM Institute).

** To whom correspondence should be addressed: Dept. of Clinical Chemistry, Lund University, University Hospital, Malmö, S-205 02 Malmö, Sweden. Tel.: 46-40-331421; Fax: 46-40-929023; E-mail: johan. stenflo@klkemi.mas.lu.se.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Yang, Y.-J. Chang, S.-W. Lin, and P. N. Walsh
Identification of Residues Asn89, Ile90, and Val107 of the Factor IXa Second Epidermal Growth Factor Domain That Are Essential for the Assembly of the Factor X-activating Complex on Activated Platelets
J. Biol. Chem., November 5, 2004; 279(45): 46400 - 46405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Blostein, B. C. Furie, I. Rajotte, and B. Furie
The Gla Domain of Factor IXa Binds to Factor VIIIa in the Tenase Complex
J. Biol. Chem., August 15, 2003; 278(33): 31297 - 31302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Shikamoto, T. Morita, Z. Fujimoto, and H. Mizuno
Crystal Structure of Mg2+- and Ca2+-bound Gla Domain of Factor IX Complexed with Binding Protein
J. Biol. Chem., June 20, 2003; 278(26): 24090 - 24094.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Thiec, G. Cherel, and O. D. Christophe
Role of the Gla and First Epidermal Growth Factor-like Domains of Factor X in the Prothrombinase and Tissue Factor-Factor VIIa Complexes
J. Biol. Chem., March 14, 2003; 278(12): 10393 - 10399.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.